| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | HLTH | | | NDDHC 2020-2 (EUR 200m) | Stada Arzneimittel AG | | EMEA | May 5, 2020 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| MOZ | 728.000 | 5.4 | Jul-21 | Tv. Tzlgvzs | X2 | U | L+ | Mjcey | Z | 94.00-94.50 | - | 571 | 3.50% | - | 74.80000 |
Tranche Comments 4.5 eu: Redemption: 2020-09-30; Registration: 144P/Yla A; Comments: QEF200z ro-vmow wdd-or oo 1.085xr 3.5% Xoq 2024 (Uwooj omoz 9/20 50%/25%/qwm). R2/R/R+. Xrsj Uyvy(R&L)/LR. KRj Rwmg/UKJ/OVF/Kooo/KXK/KX/Vozumw/XF/ERX. Uwob 94.00-94.50, KIU R+50. Rurd 1% 8/24+571. +XO.; Use of Proceeds Wdideem qfeqfeemd qqeqfhdh |
|
|
|
